LIVE FROM SEC EDGAR
Every SEC filing that moves stocks, the minute it lands.
Earnings, insider buys and sells, 5% stakes, IPO filings and red flags, summarized in plain English.
8-KInsider
5% stakeIPORed flag
center = newest
Filings per hour last 24 hours
Acrivon Therapeutics, Inc.ACRV · Nov 6, 8:00 AM ET
Acrivon acquires ACR-525 JAK1 inhibitor from Aqilion for undisclosed cash
Acrivon Therapeutics acquired the Phase 2-ready oral JAK1 inhibitor ACR-525 and a PKCθ inhibitor preclinical program from Aqilion AB for undisclosed cash, targeting eosinophilic esophagitis first.
AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.